Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A
Boutary et al. describe siRNA based therapy conjugated with squalene nanoparticles as an efficient approach to normalize PMP22 protein levels, restore locomotor activity, electrophysiological parameters and function of myelin sheath in CMT1A mouse models. These findings could be useful to develop th...
Main Authors: | Suzan Boutary, Marie Caillaud, Mévidette El Madani, Jean-Michel Vallat, Julien Loisel-Duwattez, Alice Rouyer, Laurence Richard, Céline Gracia, Giorgia Urbinati, Didier Desmaële, Andoni Echaniz-Laguna, David Adams, Patrick Couvreur, Michael Schumacher, Charbel Massaad, Liliane Massaad-Massade |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-021-01839-2 |
Similar Items
-
Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer.
by: Giorgia Urbinati, et al.
Published: (2015-01-01) -
Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma
by: Carlos Rodríguez-Nogales, et al.
Published: (2020-07-01) -
Effects of siRNA on RET/PTC3 junction oncogene in papillary thyroid carcinoma: from molecular and cellular studies to preclinical investigations.
by: Hafiz Muhammad Ali, et al.
Published: (2014-01-01) -
Synthesis of a deuterated probe for the confocal Raman microscopy imaging of squalenoyl nanomedicines
by: Eric Buchy, et al.
Published: (2016-06-01) -
Knocking Down TMPRSS2-ERG Fusion Oncogene by siRNA Could be an Alternative Treatment to Flutamide
by: Giorgia Urbinati, et al.
Published: (2016-01-01)